Tagged with

PricewaterhouseCoopers Pvt Ltd PwC is undoubtedly renowned for its strong network of international expertise, but every market still has its own particularities… What is it, that your clients struggle with the most in India? The Indian market is a very price-sensitive market. For companies active in the area of branded generics, this is…

Remedica How do you explain that despite the Bolar exemption, a high number of scientists, a very educated population, and Europe’s lowest tax rate, Cyprus has never been able to attract FDI in either manufacturing or R&D? On the one hand, Cyprus seems an attractive place from a geographical and tax…

Zdravlje Actavis Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma. What have been the main factors that got Actavis into this leading position? Ever since it was founded in 1953, Zdravlje has traditionally been one of the leading players in the Serbian…

Galenika From a Zemun-based Belgrade drug manufacturer, Galenika has grown into a leader in Serbia with an increasing footprint worldwide. How would you describe the company today? In its 65 year-long history of drug manufacturing, Galenika has experienced various stages of development. Out of a small factory in former Yugoslavia, founded…

SIRO Clinpharm Pvt Ltd Undeniably, the landscape for CROs has dramatically changed compared to when you started in the 1990s. The idea of having India as a clinical research destination was not mature yet at that time. Has India reached that desired level of maturity today? India has indeed matured compared to when we…

Pharmaceutical Reearch Institute Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for the Polish pharmaceutical industry. In the 1960s the institute became part of what was known as the state-owned “Polfa” consortium…

Merck Russia Merck KGaA describes itself as the world’s oldest pharmaceutical and chemicals company. What is the company’s history here in Russia? The Russian subsidiary was actually incorporated over 100 years ago. Last year, we celebrated 110 years of company presence in this market! The Russian office was the third office that…

Ipsen Russia Ipsen has recently announced the acquisition of a Russian pharmaceutical license. Even before this license, Russia was already one of the largest affiliates. of the group, as of 2010. The company is clearly digging in for the long term. What does this additional step imply for operations here? You are…

UCB Russia/CIS What were the difficulties in the CIS regions around the time of the financial crisis? Were there similarities to the situation in Russia? Yes, the situation in the CIS was quite similar to Russia. I was hired two years ago, from within our French subsidiary, to reorganize UCB’s CIS business…

  Without a doubt, Malaysia shares all the major attributes of an emerging market, from the potential to expand market penetration to the increasing purchasing power of the population. So the question is: Why have only two multinationals established manufacturing facilities in the country? Why was Malaysia not added to…

Boehringer Ingelheim Russia You have been with Boehringer Ingelheim since the early days of your career in 1994. In the pharmaceutical sector, managers seem to jump from company to company quite often—but you have stayed with Boehringer Ingelheim throughout executive positions in Germany, Portugal, Ukraine, Finland, and, of course, now Russia. What has…

IMS Russia You were the former director of RMBC, which was acquired in 2008 by the IMS. How important was this acquisition in terms of positioning the IMS on the Russian market? For the IMS, in terms of strategic development, this was certainly a significant acquisition—because afterwards, the organization became the leading…